Patents by Inventor Fabio Fais

Fabio Fais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING BETAHISTINE
    Publication number: 20260199306
    Abstract: The present disclosure relates to a pharmaceutical composition comprising as active substance betahistine or a pharmaceutically acceptable salt thereof, for use in the treatment of otological or neurological disorders in a human subject by intranasal application.
    Type: Application
    Filed: December 15, 2025
    Publication date: July 16, 2026
    Inventors: Thomas MEYER, Fabio FAIS
  • COMPOSITIONS FOR PREVENTING INFECTION
    Publication number: 20260007596
    Abstract: The present disclosure relates aqueous composition comprising a mucoadhesive polymer and clay particles and methods of treating or preventing infection.
    Type: Application
    Filed: March 21, 2025
    Publication date: January 8, 2026
    Inventors: Thomas MEYER, Fabio FAIS
  • Compositions for preventing infection
    Patent number: 12280142
    Abstract: The present disclosure relates aqueous composition comprising a mucoadhesive polymer and clay particles and methods of treating or preventing infection.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: April 22, 2025
    Assignee: Altamira Medica AG
    Inventors: Thomas Meyer, Fabio Fais
  • COMPOSITIONS FOR PREVENTING INFECTION
    Publication number: 20220071893
    Abstract: The present disclosure relates aqueous composition comprising a mucoadhesive polymer and clay particles and methods of treating or preventing infection.
    Type: Application
    Filed: September 3, 2021
    Publication date: March 10, 2022
    Inventors: Thomas Meyer, Fabio Fais
  • PHARMACEUTICAL COMPOSITION COMPRISING BETAHISTINE
    Publication number: 20190365728
    Abstract: The present disclosure relates to a pharmaceutical composition comprising as active substance betahistine or a pharmaceutically acceptable salt thereof, for use in the treatment of otological or neurological disorders in a human subject by intranasal application.
    Type: Application
    Filed: August 1, 2019
    Publication date: December 5, 2019
    Inventors: Thomas MEYER, Fabio FAIS
  • FORMULATION FOR HGH AND RHIGF-1 COMBINATION
    Publication number: 20170143834
    Abstract: Pharmaceutical compositions, in particular, compositions comprising growth hormone (GH) and insulin-like growth factor (IGF-1) which are stable at a desirable pH without aggregation formation, and processes for preparing such compositions.
    Type: Application
    Filed: September 30, 2016
    Publication date: May 25, 2017
    Inventors: Enona GOPINATH, Susan PARK, Tsutomu ARAKAWA, Joël RICHARD, Fabio FAIS
  • FORMULATION FOR HGH AND RHIGF-1 COMBINATION
    Publication number: 20120270782
    Abstract: The present invention relates to pharmaceutical compositions. More particularly, the invention relates to formulations of growth hormone (GH) and insulin-like growth factor (IGF-1) combination compositions which provide stable pharmaceutical compositions without aggregation formation at a desirable pH, and to processes of preparation thereof.
    Type: Application
    Filed: November 17, 2010
    Publication date: October 25, 2012
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Enona Gopinath, Susan Park, Tsutomu Arakawa, Joël Richard, Fabio Fais